Veeva Systems Inc. (NYSE:VEEV) delivered a fiscal second-quarter report that renewed interest in profitable software growth. Revenue rose 18% year over year to $928 million, while subscription revenue increased 16% to $766.8 million. GAAP operating income climbed 40% to $275 million, lifting the operating margin to 29.6% from 24.8%.
That improvement was real, but the comparison deserves scrutiny. The prior-year quarter included a $30.6 million litigation settlement-related charge. Removing that item would put the earlier operating margin near 28.7%, making the underlying year-over-year expansion closer to one percentage point. Veeva Systems Inc. (NYSE:VEEV) is showing operating leverage, but the headline 40% increase is not a clean run rate.
Vault CRM and the Broader Platform
Subscription growth provides the strongest support for durable margins. More than 180 customers are now live on Vault CRM, including five of the top 20 biopharmaceutical companies. Veeva Systems Inc. (NYSE:VEEV) also said in August that two more top-20 companies and one large enterprise biopharma had committed to the platform, bringing its global top-20 commitments to 12.
Adoption is not limited to CRM. Veeva Systems Inc. (NYSE:VEEV) added more than 30 clinical customers, surpassed 100 Veeva Safety customers, and added more than 30 Quality Cloud customers. That breadth creates more opportunities to sell additional products across the subscription base without building a separate customer-acquisition engine for each one.
What the Adjusted Numbers Say
Company-defined non-GAAP operating income at Veeva Systems Inc. (NYSE:VEEV), which excludes stock-based compensation, acquired-intangible amortization and certain litigation-related charges, rose 18% to $415.9 million. The corresponding margin edged up to 44.8% from 44.7%. The dramatic GAAP improvement reflected both the absence of the prior-year litigation charge and slower growth in recurring adjustments such as stock-based compensation and amortization. The core business still showed leverage, but not at the rate suggested by reported GAAP operating income.
There were other reasons for caution. GAAP operating cash flow was $238.7 million, almost unchanged from $238.4 million a year earlier. Professional-services and other revenue grew 24%, but its non-GAAP gross margin declined to 31.5% from 33.4%. Normalized billings, a company-defined measure that adjusts calculated billings for customer-term changes and certain delayed renewals, rose 19%, so flat quarterly operating cash flow does not negate the stronger demand signal.
AI Remains Optionality
On August 26, CEO Peter Gassner described AI as the next major chapter for Veeva Systems Inc. (NYSE:VEEV) and life sciences. Veeva Falcon has five early adopters, while Veeva Systems Inc. (NYSE:VEEV) has expanded Vault AI agents and deployed its Agentic Call Report across a top-20 biopharma’s U.S. field team. Still, management has not quantified AI revenue or margins, and the Copli acquisition had an immaterial effect on the quarter.
For fiscal 2027, Veeva Systems Inc. (NYSE:VEEV) expects revenue of $3.682 billion to $3.687 billion and company-defined non-GAAP operating income of about $1.64 billion. That implies a margin of approximately 44.5%, which management characterized as about 44%. The outlook supports continued high profitability, but not obvious expansion from fiscal 2026’s 44.9%.
Hedge Fund Sentiment
The filings available so far reflect positions held before VEEV reported its recent results. Insider Monkey’s database showed 61 hedge funds holding VEEV at the end of 2Q2026, down from 62 funds three months earlier.
Conclusion
The margin structure at Veeva Systems Inc. (NYSE:VEEV) appears sustainable, but the latest 40% GAAP operating-income growth rate does not. Subscription growth and broader platform adoption support genuine leverage, while flat adjusted margins, softer services profitability, and limited quarterly cash-flow growth argue against extrapolating the headline increase. AI can strengthen the story, but it remains upside optionality rather than a necessary earnings assumption.
READ NEXT: ConocoPhillips (COP): Wall Street Sees More Upside Despite Leadership Shakeup and Here is Why Chevron (CVX) is a Favorite Among Hedge Funds
Disclosure: None. This article is originally published at Insider Monkey.
